Peter Kolchinsky - Jun 29, 2021 Form 4 Insider Report for Therapeutics Acquisition Corp. (PNT)

Role: Chief Executive Officer, Director
Signature: /s/ Matthew Hammond as Attorney-in-Fact
Stock symbol: PNT
Transactions as of: Jun 29, 2021
Transactions value $: $2,091,000
Form type: 4
Date filed: 6/30/2021, 04:31 PM
Previous filing: Jun 24, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PNT	Common Stock	Award	$2.09M	+209K	+23.52%	$10.00	1.1M	Jun 29, 2021	See Footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired by RA Capital Management Healthcare Fund, L.P. (the "Fund") on June 29, 2021.
F2	RA Capital Management L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which the reporting person and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, The reporting person and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Content

These shares were acquired by RA Capital Management Healthcare Fund, L.P. (the "Fund") on June 29, 2021.

RA Capital Management L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which the reporting person and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, The reporting person and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.